Interfacial biology of in-stent restenosis

References

• Nair SV, McEwan JR. Angina pectoris: interventional therapies and treatment of restenosis. Int. J. Biochem. Cell Biol. 35(10), 1399–1406 (2003).
   PubMed Web of Science ®Google Scholar
• American Heart Association. 2001 Heart and Stroke Statistical Update. American Heart Association, TX, USA (2001).
   Google Scholar
• Ruygrok PN, Webster MW, Ardill JJ et al. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient. Catheter. Cardiovasc. Interv. 59(2), 165–171 (2003).
   PubMed Web of Science ®Google Scholar
• Moreno R, Fernandez C, Alfonso F et al. Coronary stenting versus balloon angioplasty in small vessels – a meta-analysis from 11 randomized studies. J. Am. Coll. Cardiol. 43(11), 1964–1972 (2004).
   PubMed Web of Science ®Google Scholar
• Nikolsky E, Gruberg L, Pechersky S et al. Stent deployment failure: reasons, implications, and short- and long-term outcomes. Catheter. Cardiovasc. Interv. 59(3), 324–328 (2003).
   PubMed Web of Science ®Google Scholar
• Brodie BR, Cooper C, Jones M, Fitzgerald P, Cummins F. Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial. Catheter. Cardovasc. Interv. 59(2), 184–192 (2003).
   PubMed Web of Science ®Google Scholar
• Ito Y, Muramatsu T, Tsukahara R et al. Is a vessel stretch during coronary stent deployment associated with restenosis? Am. J. Cardiol. 90(6A), 1 (2002).
   PubMed Web of Science ®Google Scholar
• Vernhet H, Demaria R, Juan JM, Oliva-Lauraire MC, Senac JP, Dauzat M. Arterial stenting and overdilation: does it change wall mechanics in small-caliber arteries? J. Endovasc. Ther.9(6), 855–862 (2002).
   PubMed Web of Science ®Google Scholar
• Muller-Hulsbeck S, Grimm J, Jahnke T, Haselbarth G, Heller M. Flow patterns from metallic vascular endoprostheses: in vitro results. Eur. Radiol. 11(5), 893–901 (2001).
   PubMed Web of Science ®Google Scholar
• Yu ZX, Tamai H, Kyo E et al. Comparison of the self-expanding radius stent and the balloon-expandable multilink stent for elective treatment of coronary stenoses: a serial analysis by intravascular ultrasound. Catheter. Cardiovasc. Interv. 56(1), 40–45 (2002).
   PubMed Web of Science ®Google Scholar
• Vernhet H, Demaria R, Perez-Martin A et al. Wall mechanics of the stented rabbit aorta: long-term study and correlation with histological findings. J. Endovasc. Ther. 10(3), 577–584 (2003).
   PubMed Web of Science ®Google Scholar
• Sudhir K, Hashimura K, Bobik A, Dilley RJ, Jennings GL, Little PJ. Mechanical strain stimulates a mitogenic response in coronary vascular smooth muscle cells via release of basic fibroblast growth factor. Am. J. Hypertens. 14, 1128–1134 (2001).
   PubMed Web of Science ®Google Scholar
• Virmani R, Farb A. Pathology of in-stent restenosis. Curr. Opin. Lipidol. 10(6), 499–506 (1999).
   PubMed Web of Science ®Google Scholar
• Virmani R. Self-expanding stent deployment strategies may be the key to reducing in-stent restenosis. Catheter. Cardiovasc. Interv. 56(4), 487–488 (2001).
   Web of Science ®Google Scholar
• Cafri C, Weinstein JM, Gilutz H, Kobal S, Ilia R. Low-pressure deployment of stents: short- and long-term outcome. Coron. Artery Dis. 12(4), 313–316 (2001).
   PubMed Web of Science ®Google Scholar
• Pan M, de Lezo JS, Medina A et al. Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions. Catheter. Cardiovasc. Interv. 58(3), 293–300 (2003).
   PubMed Web of Science ®Google Scholar
• Briguori C, Sarais C, Pagnotta P et al. In-stent restenosis in small coronary arteries – impact of strut thickness. J. Am. Coll. Cardiol. 40(3), 403–409 (2002).
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Muhlestein JB, Anderson JL et al. Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment. Am. J. Cardiol. 90(3), 299–304 (2002).
   PubMed Web of Science ®Google Scholar
• Dobesh PP, Stacy ZA, Ansara AJ, Enders JM. Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. Pharmacotherapy 24(11), 1554–1577 (2004).
   PubMed Web of Science ®Google Scholar
• Tanabe K, Serruys PW, Grube E et al. TAXUS III trial – in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107(4), 559–564 (2003).
   PubMed Web of Science ®Google Scholar
• Silber S. When are drug-eluting stents effective? A critical analysis of the presently available data. Z. Kardiol. 93(9), 649–663 (2004).
   PubMedGoogle Scholar
• Fajadet J, Morice MC, Bode C et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents – three-year results of the RAVEL trial. Circulation 111(8), 1044–1048 (2005).
   Google Scholar
• Karthikeyan G, Bhargava B. Prevention of restenosis after coronary angioplasty. Curr. Opin. Cardiol. 19(5), 500–509 (2004).
   PubMed Web of Science ®Google Scholar
• Marchetti M. Drug-eluting stents: from evidences to policy. Exp. Rev. Med. Dev. 1(1), 49–63 (2004).
   PubMed Web of Science ®Google Scholar
• Park SJ, Shim WH, Ho DS et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N. Engl. J. Med. 348(16), 1537–1545 (2003).
   PubMed Web of Science ®Google Scholar
• Abizaid A, Costa MA, Blanchard D et al. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients – insights from the RAVEL Trial. Eur. Heart J. 25(2), 107–112 (2004).
   PubMed Web of Science ®Google Scholar
• Farb A, Sangiorgi G, Carter AJ et al. Pathology of acute and chronic choronary stenting in humans. Circulation 99, 44–52 (1999).
   PubMed Web of Science ®Google Scholar
• Farb A, Weber DK, Weber MS, Kolodgie FK, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105, 2974–2980 (2002).
   PubMed Web of Science ®Google Scholar
• Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108(14), 1701–1706 (2003).
   PubMed Web of Science ®Google Scholar
• Farb A, Kolodgie FD, Hwang JY et al. Extracellular matrix changes in stented human coronary arteries. Circulation 110(8), 940–947 (2004).
   PubMed Web of Science ®Google Scholar
• Skowasch D, Jabs A, Andrie R et al. Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis – tissue characteristics compared to primary atherosclerosis. J. Vasc. Res. 41(6), 525–534 (2004).
   PubMed Web of Science ®Google Scholar
• Turley EA. Extracellular matrix remodeling multiple paradigms in vascular diseases. Circ. Res. 88, 2–4 (2001).
   PubMed Web of Science ®Google Scholar
• Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J. Am. Coll. Cardiol. 40(12), 2072–2081 (2002).
   PubMed Web of Science ®Google Scholar
• Sakai T, Inoue S, Otsuka T et al. Cell cycle regulator expression after coronary stenting in humans – immunohistochemical examination. Jpn Heart J. 45(1), 133–145 (2004).
   PubMedGoogle Scholar
• Peuster M, Fink C, Reckers J, Beerbaum P, von Schnakenburg C. Assessment of subacute inflammatory and proliferative response to coronary stenting in a porcine model by local gene expression studies and histomorphometry. Biomaterials 25(6), 957–963 (2004).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, Campbell JH, Carlson PJ, Holmes DR, Schwartz RS. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery and repair. Atherosclerosis 163(1), 89–98 (2002).
   PubMed Web of Science ®Google Scholar
• Shoji M, Sata M, Fukuda D et al. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc. Pathol. 13(6), 306–312 (2004).
   PubMed Web of Science ®Google Scholar
• Tuleta I, Jabs A, Andrie R et al. Dendritic cells contribute to in-stent restenosis: recruitment in early neointima formation after porcine aortic stent implantation and in human in-stent restenosis. J. Am. Coll. Cardiol. 43(5), 54A (2004).
   Google Scholar
• Dirsch O, Dahmen U, Fan LM et al. Media remodeling – the result of stent induced media necrosis and repair. VASA-J. Vasc. Dis. 33(3), 125–129 (2004).
   PubMedGoogle Scholar
• Virmani R, Liistro F, Stankovic G et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106, 2649–2651 (2002).
   PubMed Web of Science ®Google Scholar
• Gutensohn K, Beythien C, Bau J et al. In vitro analysis of diamond-like carbon coated stents: reduction of metal ion release, platelet activation and thrombogenicity. Thromb. Res. 99, 577–585 (2000).
   PubMed Web of Science ®Google Scholar
• Santin M, Mikhalovska L, Lloyd AW et al. In vitro host response assessment of biomaterials for cardiovascular stent manufacture. J. Mater. Sci. Mater. Med. 15, 473–477 (2004).
   PubMed Web of Science ®Google Scholar
• Del Rizzo DF, Yurkova N, Moon MC, Litchie B, Zahradka P. Platelet-derived growth factor-induced expression of c-fos in human vascular smooth muscle cells: implications for long-term graft patency. Ann. Thorac. Surg. 74, 90–95 (2002).
   PubMed Web of Science ®Google Scholar
• Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283–289 (2004).
   PubMed Web of Science ®Google Scholar
• Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22, 1769–1776 (2002).
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature Insight 407, 249–257 (2000).
   Google Scholar
• Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14(11), 628–638 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl Acad. Sci. USA 100, 2426–2431 (2003).
   PubMed Web of Science ®Google Scholar
• Campbell JH, Mooney J, Sester D, Campbell GR. Differentiation of macrophages into myofibroblasts. J. Mol. Cell. Cardiol. 37(1), 326–327 (2004).
   Google Scholar
• Wilcox JN, Okamoto E, Nakahara K, Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis – a role for circulating myofibroblast precursors? Ann. NY Acad. Sci. 947, 68–92 (2001).
   PubMed Web of Science ®Google Scholar
• Davis TA, Lennon G. Mice with a regenerative wound healing capacity and an SLE autoimmune phenotype contain elevated numbers of circulating and marrow-derived macrophage progenitor cells. Blood Cells Mol. Dis. 34(1), 17–25 (2004).
   Web of Science ®Google Scholar
• Hu M, Sableman EE, Cao Y, Chang J, Hentz VR. Three-dimensional hyaluronic acid grafts promote healing and reduce scar formation in skin incision wounds. J. Biomed. Mater. Res. B Appl. Biomat. 67B(1), 586–592 (2003).
   Web of Science ®Google Scholar
• Rees MD, Hawkins CL, Davies MJ. Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulfates. Biochem. J. 381, 175–184 (2004).
   PubMed Web of Science ®Google Scholar
• Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL. Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts. Circ. Res. 88, 77–83 (2001).
   PubMed Web of Science ®Google Scholar
• Leite PF, Liberman M, de Brito FS, Laurindo FRM. Redox processes underlying the vascular repair reaction. World J. Surg. 28(3), 331–336 (2004).
   PubMed Web of Science ®Google Scholar
• Tanimoto K, Suzuki A, Ohno S et al. Effects of TGF-β on hyaluronan anabolism in fibroblasts derived from the synovial membrane of the rabbit temporomandibular joint. J. Dent. Res. 83(1), 40–44 (2004).
   PubMed Web of Science ®Google Scholar
• Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation. J. Biol. Chem. 279(10), 8753–8760 (2004).
   PubMed Web of Science ®Google Scholar
• Horton MR, Olman MA, Bao C et al. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 279(4), 707–715 (2000).
   PubMed Web of Science ®Google Scholar
• Mytar B, Siedlar M, Woloszyn M, Colizzi V, Zembala M. Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation: the essential role of hyaluronan. Int. J. Cancer 94(5), 727–732 (2001).
   PubMed Web of Science ®Google Scholar
• Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 278(34), 32259–32265 (2003).
   PubMed Web of Science ®Google Scholar
• Teder P, Vandivier RW, Jiang DH et al. Resolution of lung inflammation by CD44. Science 296(5565), 155–158 (2002).
   PubMed Web of Science ®Google Scholar
• Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169(8), 4322–4331 (2002).
   PubMed Web of Science ®Google Scholar
• Linder S, Pinkowski W, Aepfelbacher M. Adhesion, cytoskeletal architecture and activation status of primary human macrophages on a diamond-like carbon coated surface. Biomaterials 23, 767–775 (2002).
   PubMed Web of Science ®Google Scholar
• Rhodes NP, Hunt JA, Williams DF. Macrophage subpopulation differentiation by stimulation with biomaterials. J. Biomed. Mater. Res. 37, 481–488 (1997).
   PubMed Web of Science ®Google Scholar
• Krettek A, Ostergren-Lunden G, Fager G, Rosmond C, Bondjers G, Lustig F. Expression of PDGF receptors and ligand-induced migration of partially differentiated human monocyte-derived macrophages. Influence of IFN-γ and TGF β. Atherosclerosis 156, 267–275 (2001).
   PubMed Web of Science ®Google Scholar
• Sudhir K, Hashimura K, Bobik A, Dilley RJ, Jennings GL, Little P. Mechanical strain stimulates a mitogenic response in coronary vascular smooth muscle cells via release of basic fibroblast growth factor. Am. J. Hypertens. 14, 1128–1134 (2001).
   PubMed Web of Science ®Google Scholar
• Palumbo R, Gaetano C, Melillo G, Toschi E, Remuzzi A, Capogrossi MC. Shear stress downregulation of platelet-derived growth factor receptor-b and matrix metalloproteinase-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 102, 225 (2000).
   PubMed Web of Science ®Google Scholar
• Zhou RH, Lee TS, Tsou TC et al. Stent implantation activates Akt in the vessel wall role of mechanical stretch in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23(11), 2015–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Cirri P, Taddei ML et al. New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases. J. Cell Sci. 115(10), 2219–2232 (2002).
   PubMed Web of Science ®Google Scholar
• Cartel NJ, Post M. Abrogation of apoptosis through PDGF-BB-induced sulfated glycosaminoglycan synthesis and secretion. Am. J. Physiol. Lung Cell. Mol. Physiol. 288(2), 285–293 (2005).
   Google Scholar
• Ferguson MWJ, O’Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1445), 839–850 (2004).
   PubMed Web of Science ®Google Scholar
• Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhla J, Wight TN. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch. Biochem. Biophys. 394(1), 29–38 (2001).
   PubMed Web of Science ®Google Scholar
• Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int. 58(5), 1953–1962 (2000).
   PubMed Web of Science ®Google Scholar
• Santin M, Morris C, Harrison M, Mikhalovska L, Lloyd AW, Mikhalovsky S. Factors inducing in-stent restenosis: an in vitro model. Med. J. Malaysia 59(B), 93–94 (2004).
   PubMedGoogle Scholar
• Velling T, Nilsson S, Stefansson A, Johansson S. β1-integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases. EMBO reports 5, 901–905 (2004).
   PubMed Web of Science ®Google Scholar
• Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S. Polymerization of Type I and III collagens is dependent on fibronectin and enhanced by integrin α11β1 and α2β1. J. Biol. Chem. 277(40), 37377–37381 (2002).
   PubMed Web of Science ®Google Scholar
• Kingsley K, Rust WL, Huff JL, Smith RC, Plopper GE. PDGF-BB enhances expression of, and reduces adhesion to, laminin-5 in vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 294, 1017–1022 (2002).
   PubMed Web of Science ®Google Scholar
• Kingsley K, Huff JL, Rust WL et al. ERK 1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem. Biophys. Res. Comm. 293, 1000–1006 (2002).
   PubMed Web of Science ®Google Scholar
• Doevendans PA, van Eys G. Smooth muscle cells on the move: the battle for actin. Cardivasc. Res. 54(3), 499–502 (2002).
   PubMed Web of Science ®Google Scholar
• Kramer J, Quensel C, Meding J, Cardoso MC, Leonhardt H. Indentification and characterization of novel smoothelin isoform in vascular smooth muscle. J. Vasc. Res. 38, 120–132 (2001).
   PubMed Web of Science ®Google Scholar
• Cuff CA, Kothapalli D, Azonobi I et al. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108(7), 1031–1040 (2001).
   PubMed Web of Science ®Google Scholar
• Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 111(7), 926–931 (2005).
   PubMed Web of Science ®Google Scholar
• Han CI, Campbell GR, Campbell JH, Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res. 38, 113–119 (2001).
   PubMed Web of Science ®Google Scholar
• Kocijan A, Milosev I, Pihlar B. The influence of complexing agent and proteins on the corrosion of stainless steels and their metal components. J. Mater. Sci. Mater. Med. 14, 69–77 (2003).
   PubMed Web of Science ®Google Scholar
• Shabalovskaya SA, Anderegg J, Laab F, Thiel PA, Rondelli G. Surface conditions of nitinol wires, tubing, and as-cast alloys, the effect of chemical etching, aging in boiling water, and heat treatment. J. Biomed. Mater. Res. B Appl. Biomater. 65B, 193–203 (2003).
   Web of Science ®Google Scholar
• Huang N, Yang P, Leng YX et al. Hemocompatibility of titanium oxide films. Biomaterials 24, 2177–2187 (2003).
   PubMed Web of Science ®Google Scholar
• Mikhalovska LI, Santin M, Denyer SP et al. Fibrinogen adsorption and platelet adhesion to metal and carbon coatings. Thromb. Haemost. 92, 1032–1039 (2004).
   PubMed Web of Science ®Google Scholar
• Antoniucci D, Bartorelli A, Valenti R et al. Clinical and angiographic outcome after coronary arterial stenting with the carbostent. Am. J. Cardiol. 85(7), 821–825 (2000).
   PubMed Web of Science ®Google Scholar
• Unverdorben M, Sippel B, Degenhardt R et al. Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study’s long-term outcome. Am. Heart J. 145(4), 9–17 (2003).
   PubMed Web of Science ®Google Scholar
• Hanekamp C, Koolen J, Bonnier H et al. Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am. J. Cardiol. 93(10) 1233–1237 (2004).
   PubMed Web of Science ®Google Scholar
• Kedev S, Guagliumi G, Valsechi O, Tespili M. Heparin-coated versus uncoated Palmaz-Schatz stent in native coronary circulation. A randomized study with blind angioscopic assessment. Int. J. Artif. Organs 25(5), 461–469 (2002).
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee CW, Hong MK et al. Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. Am. J. Cardiol. 89(7), 872–877 (2002).
   PubMed Web of Science ®Google Scholar
• Grenadier E, Roguin A, Hertz I et al. Stenting very small coronary narrowings (< 2 mm) using the biocompatible phosphorylcholine-coated coronary stent. Catheter. Cardiovasc. Interv. 55(3), 303–308 (2002).
   PubMed Web of Science ®Google Scholar
• Castner DG, Ratner BD. Biomedical surface science: foundations to frontiers. Surf. Sci. 500, 28–60 (2002).
   Web of Science ®Google Scholar
• West NEJ, Ruygrok PN, Disco CMC et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 109(7), 867–873 (2004).
   PubMed Web of Science ®Google Scholar
• Gomma AH, Hirschfield GM, Gallimore JR, Lowe GDO, Pepys MB, Fox KM. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am. Heart J. 147(6), 1071–1077 (2004).
   PubMed Web of Science ®Google Scholar
• Sousa EJ, Costa MA, Sousa AGMR. What is ‘the matter’ with restenosis in 2002? Circulation 105, 2932–2933 (2002).
   PubMed Web of Science ®Google Scholar